Summit Cancer Center Director, Arvind Chaudhry, MD, PhD, to Chair Coeur d'Alene Hematology Oncology Conference Focused on Precision-Guided Cancer Care
SPOKANE, Wash., Oct. 9, 2025 /PRNewswire/ -- Summit Cancer Centers Founder and Medical Director Dr. Arvind Chaudhry will chair the Coeur d'Alene Hematology Oncology Conference on October 11, 2025, at the Coeur d'Alene Resort. The continuing medical education (CME) event will focus on precision-guided management in oncology, offering 6.0 CME credits, MOC II points, and ACPE credits for participating clinicians.
The conference, part of the nationally recognized Binaytara CME Conference Series, has become a cornerstone of regional medical education. Founded in collaboration with Dr. Binay Shah, president and co-founder of the Binaytara Foundation, the series began in 2015 as a small gathering reviewing ASCO and ASH highlights. It has since evolved into a leading annual event drawing oncology professionals from across the country.
"Our goal is to have a healthy discussion and not just a lecture," said Dr. Chaudhry. "We want all cancer-treating doctors—medical oncologists, radiation oncologists, and surgical oncologists—involved, almost like a tumor board format."
Dr. Chaudhry will also chair the lung cancer session, a timely focus as the field continues to evolve with a surge of FDA approvals for targeted and immune therapies. "It is very exciting, the number of drugs now approved every year," he said. "Treatments that were once tested in advanced disease are now being used earlier, both before and after surgery. Those are major advances."
Dr. Chaudhry's leadership extends beyond education to advancing clinical research in community settings. His recent participation in the Artistry-1 trial tested a novel immunotherapy for melanoma and renal cell carcinoma and demonstrates the impact of expanding access to early-phase trials locally. The study provided a safer alternative to older IL-2 treatments, highlighting the potential for groundbreaking research outside large academic centers.
"Summit Cancer Centers is committed to closing the gap between discovery and delivery," Dr. Chaudhry said. "By combining clinical research with education, we ensure that new treatments reach patients faster and more effectively."
The Coeur d'Alene conference embodies this vision, bringing together community oncologists and leading experts from institutions including Seattle, Portland, and Stanford for practical, case-based discussions designed to improve outcomes across the region.
For details about the Coeur d'Alene Hematology Oncology Conference, visit binaytara.org/conferences.
To learn more about Summit Cancer Centers, visit summitcancercenters.com.
Media Inquiries/Contact:
John Driscoll
Summit Cancer Centers
509-462-2273
402447@email4pr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/summit-cancer-center-director-arvind-chaudhry-md-phd-to-chair-coeur-dalene-hematology-oncology-conference-focused-on-precision-guided-cancer-care-302579325.html
SOURCE Summit Cancer Centers